FIGURE

Fig. 6

ID
ZDB-FIG-190724-19
Publication
Seda et al., 2019 - An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

Dose-response of leflunomide treatment. Representative images in ventral view at 5 days post-fertilization showing effects of indicated doses of leflunomide treatment from 50% epiboly.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol. Syndromol.